Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
Eleven Biotherapeutics reports 2019 executive compensation
By ExecPay News
Published: March 25, 2021
Eleven Biotherapeutics reported fiscal year 2019 executive compensation information on March 25, 2021.
In 2019, four executives at Eleven Biotherapeutics received on average a compensation package of $900K, a 18% decrease compared to previous year.
Average pay of disclosed executives at Eleven Biotherapeutics
Thomas R. Cannell, Chief Executive Officer, received $1.4M in total, which decreased by 30% compared to 2018. 40% of Cannell's compensation, or $568K, was in option awards. Cannell also received $312K in non-equity incentive plan, $520K in salary, as well as $4K in other compensation.
Mark R. Sullivan, General Counsel, received a compensation package of $938K. 49% of the compensation package, or $457K, was in salary.
Monica Forbes, Chief Financial Officer, earned $675K in 2019.
Glen MacDonald, Chief Technology Officer, received $583K in 2019.
Related executives
You may also like
Source: SEC filing on March 25, 2021.